Sangamo Therapeutics
SGMO
SGMO
190 hedge funds and large institutions have $476M invested in Sangamo Therapeutics in 2020 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 64 increasing their positions, 47 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
3.54% less ownership
Funds ownership: 67.7% → 64.16% (-3.5%)
28% less capital invested
Capital invested by funds: $657M → $476M (-$181M)
Holders
190
Holding in Top 10
–
Calls
$7.91M
Puts
$6.71M
Top Buyers
| 1 | +$14.7M | |
| 2 | +$12.9M | |
| 3 | +$9.48M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$6.59M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$4.04M |
Top Sellers
| 1 | -$64.8M | |
| 2 | -$11.3M | |
| 3 | -$9.86M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$7.6M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3.52M |